Ascendis Pharma is a global biopharmaceutical company headquartered in Copenhagen, Denmark, specializing in the development of innovative therapies using its proprietary TransCon technology platform. ... Ascendis Pharma is a global biopharmaceutical company headquartered in Copenhagen, Denmark, specializing in the development of innovative therapies using its proprietary TransCon technology platform. The company focuses on addressing unmet medical needs across endocrinology, rare diseases, and oncology. Its pipeline includes TransCon hGH for growth hormone deficiency, TransCon CNP for achondroplasia, and TransCon PTH for hypoparathyroidism, along with oncology candidates in development. Ascendis conducts clinical trials across the United States, Europe, and multinational markets, with strategic partnerships extending development efforts to Asia through entities like VISEN Pharmaceuticals in Greater China and collaborations in Japan. The company operates research facilities in Germany and offices throughout Europe and the United States, maintaining a commitment to improving treatment safety, efficacy, tolerability, and patient convenience through its innovative drug development approach.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Energy Management data not yet covered for Ascendis Pharma

We have not yet reviewed Ascendis Pharma's disclosures for Energy Management data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Ascendis Pharma's data?

Start your 30-day free trial to request a data review for Ascendis Pharma.

Start Free Trial

Legal Center Contact Us

Ascendis Pharma A/S

Energy Management data not yet covered for Ascendis Pharma

Account Restricted